Clinical Trials List
Protocol Number3144A2-3004-WW
2009-11-15 - 2019-12-31
Phase III
Terminated3
-
Trial Applicant
PAREXEL INTERNATIONAL CO., LTD.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Chi-Chang Yu Division of General Surgery
- Hsien-Kun Chang Division of General Surgery
- Wen-Ling Kuo Division of General Surgery
- Wen-Chi Shen Division of General Surgery
- Yung-Chang Lin Division of General Surgery
- 沈士哲 Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Co-Principal Investigator
- Fu Ouyang Division of Hematology & Oncology
- Chieh-Han Chuang Division of Hematology & Oncology
- Fang-Ming Chen Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Stop recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
2842 participants
